| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Email Marketing > Email Marketing - How Often Should You Mail? Part 1 |
|
Main Subject - Email Marketing - How Often Should You Mail? Part 1
This is a highly debated subject and many different marketers use many diffe According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product rent frequencies of mailing. The difficulty with this is that each email li ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in t is a market on its own. You see, each keyword around which you might buil lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. your list, is a market on its own. Then, you are writing your own articles here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe r driving your own traffic – which makes your list even more unique. So it d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s difficult to compare response rates from list to list. Here is the thing ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc about frequency of mailing: The more frequently you mail, the more sales yo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi will make, the more unsubscribes you will get, the lower your open rates wi nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically l be and the lower your click through rates will be. On the other hand, the and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ less frequently you mail, the higher your conversion rates will be, the fewe ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi unsubscribes you will get (unless you mail sporadically, then the unsubscri ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a be rate will go up again), the higher your open rates will be and the higher dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod your click through rates will be. Of course, all of this is subject to ‘all cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin things being equal’. At first glance, you might think that mailing less fre tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen uently is better: higher conversion rates, everything else is better. You t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ight also think that I have gotten the first part of mailing more frequently ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust wrong: more sales. Generally, my experience has been that the more frequen y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ly I mail, the more sales I make, even if the conversion rate is lower. The . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de bottom line is, you have to test your own list and come up with your own co elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip version rates. There is no absolute! You have to do what works best for yo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Six Small Business Management Tools Can Make You Rich!
|